Spyre Therapeutics Inc

NEW
STU:3920 (USA)  
€ 85 -2.5 (-2.86%) Jul 31
At Loss
P/B:
15.05
Market Cap:
€ 7.41B ($ 8.54B)
Enterprise V:
€ 6.90B ($ 7.96B)
Volume:
20.00
Avg Vol (2M):
86.00
Trade In:

Spyre Therapeutics Inc Operating Data

Spyre Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

Spyre Therapeutics Inc (STU:3920) Operating Data Charts